June 16, 2022 Webinar
1:00pm – 2:00pm EDT
Register here.
Late stage private placements with institutional investors, crossover investors, corporate venture capital (CVC) funds, and strategic investors raise a number of considerations distinct from those arising in earlier stage and venture financing transactions. Privately held companies have been more comfortable sponsoring liquidity programs for
March 31 – April 1, 2022 Webinar
Register here.
Mayer Brown invites you to the Practising Law Institute’s Private Placements and Hybrid Securities Offerings 2022 virtual conference.
Private Placements and Hybrid Securities Offerings 2022 will cover the basics of private placements, resales of restricted securities, Section 4(a)(1-1/2) transactions and block trades. The program will
The SEC’s Office of the Advocate for Small Business Capital Formation (“OASB”) recently issued its 2021 Annual Report (the “Report”), which reviews the capital raising activities of a variety of companies, from startups and emerging businesses to smaller public companies. The OASB, together with the SEC’s Division of Economic and Risk Analysis, provided updated data
This practice note discusses lock-up agreements between underwriters or placement agents, on the one hand, and issuers and their directors, officers, and control persons, on the other, in connection with offerings of securities.
Read the full article here.
In the International Financial Law Review’s latest publication, A Deep Dive Into Capital Raising Alternatives, Mayer Brown provides context on the changes in market structure and market dynamics that led to the enactment of the JOBS Act. Specifically, the trend for many private companies to remain private longer, defer or dispense with traditional
This practice note discusses recent market trends regarding lock-up agreements, which are usually negotiated between the underwriters or placement agents and the issuer and its directors, officers, and control persons in connection with offerings of securities.
Read the full article here.
Sunday, July 19, 2020
9:00 a.m. – 10:00 a.m. EDT
4:00 p.m. – 5:00 p.m. Israel Time
Register here
Join Mayer Brown and PwC for a webinar on Life Sciences IPOs. Panelists will discuss the pre-IPO and IPO markets and IPO preparedness, among other topics. CEO and Co-Founder of InMode, Moshe Mizrahy, will join our
Kevin Gsell, Head of Legal Solutions & Partnerships at Nasdaq Private Markets, joined our annual session on late stage or pre-IPO private placements earlier this week. As discussed during our session, as companies choose to remain private longer, and defer liquidity events, early investors and employees require liquidity opportunities. In fact, in many cases, the
Professor Anat Alon-Beck from the School of Law at Case Western Reserve University joined our annual conference on Late Stage Private Placements earlier this week. Prof. Beck spoke about the unicorn phenomenon, valuation concerns relating to unicorns and the new investors that have fueled the growth of unicorns. Prof. Beck’s slides may be accessed here
During the first quarter of 2020, venture funding levels in the global healthcare and life sciences sector has increased 4% by dollars raised, quarter-over-quarter, despite the turbulent COVID-19 environment. According to a recent CB Insights report, healthcare companies raised $14.6 billion this past quarter in 1,156 deals. Deal volume decreased 6% quarter-over-quarter. The inverse